OptimizeRx (NASDAQ:OPRX) vs. Triple P (OTCMKTS:TPPPF) Critical Comparison

OptimizeRx (NASDAQ:OPRX) and Triple P (OTCMKTS:TPPPF) are both computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and profitability.

Volatility and Risk

OptimizeRx has a beta of 1.13, suggesting that its stock price is 13% more volatile than the S&P 500. Comparatively, Triple P has a beta of 3.05, suggesting that its stock price is 205% more volatile than the S&P 500.

Profitability

This table compares OptimizeRx and Triple P’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
OptimizeRx	6.37%	10.86%	7.93%
Triple P	N/A	N/A	N/A

Valuation & Earnings

This table compares OptimizeRx and Triple P”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptimizeRx	$109.43 million	0.91	$5.13 million	$0.35	15.09
Triple P	N/A	N/A	N/A	N/A	N/A

OptimizeRx has higher revenue and earnings than Triple P.

Insider and Institutional Ownership

76.5% of OptimizeRx shares are owned by institutional investors. 5.6% of OptimizeRx shares are owned by insiders. Comparatively, 39.0% of Triple P shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for OptimizeRx and Triple P, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OptimizeRx	1	2	6	0	2.56
Triple P	0	0	0	0	0.00

OptimizeRx presently has a consensus price target of $13.43, suggesting a potential upside of 154.33%. Given OptimizeRx’s stronger consensus rating and higher probable upside, equities research analysts plainly believe OptimizeRx is more favorable than Triple P.

Summary

OptimizeRx beats Triple P on 8 of the 10 factors compared between the two stocks.

About OptimizeRx

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

About Triple P

Triple P. N.V. provides information and communication technology (ICT) infrastructure solutions. Its services include ICT security, cloud, managed services, managed IP telephony, professional services, business continuity, unified communications, and cloud migration. The company serves care, education, government, and commercial services sectors. Triple P. N.V. was founded in 1989 and is headquartered in Nieuwegein, the Netherlands.